Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Oligonucleotide Pool Market Research Report Information By Type (DNA and RNA), By Application (Research, Diagnostic & Therapeutics, and Others), By End-User (Commercial Research, Pure Academic Research, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/LS/1916-CR | 110 Pages | Author: Kinjoll Dey| August 2019

Oligonucleotide Pool Market Segmentation


Oligonucleotide Pool Type Outlook (USD Billion, 2018-2032)




  • DNA




  • RNA




Oligonucleotide Pool Application Outlook (USD Billion, 2018-2032)




  • Research




  • Diagnostic & Therapeutics




  • Others




Oligonucleotide Pool End-User Outlook (USD Billion, 2018-2032)




  • Commercial Research




  • Pure Academic Research




  • Others




Oligonucleotide Pool Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Oligonucleotide Pool by Type




      • DNA




      • RNA






    • North America Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • North America Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • US Outlook (USD Billion, 2018-2032)




    • US Oligonucleotide Pool by Type




      • DNA




      • RNA






    • US Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • US Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Oligonucleotide Pool by Type




      • DNA




      • RNA






    • CANADA Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • CANADA Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Europe Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Europe Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Germany Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Germany Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • France Outlook (USD Billion, 2018-2032)




    • France Oligonucleotide Pool by Type




      • DNA




      • RNA






    • France Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • France Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • UK Outlook (USD Billion, 2018-2032)




    • UK Oligonucleotide Pool by Type




      • DNA




      • RNA






    • UK Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • UK Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Oligonucleotide Pool by Type




      • DNA




      • RNA






    • ITALY Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • ITALY Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Spain Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Spain Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Oligonucleotide Pool by Type




      • DNA




      • RNA






    • REST OF EUROPE Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Rest Of Europe Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Asia-Pacific Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Asia-Pacific Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • China Outlook (USD Billion, 2018-2032)




    • China Oligonucleotide Pool by Type




      • DNA




      • RNA






    • China Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • China Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Japan Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Japan Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • India Outlook (USD Billion, 2018-2032)




    • India Oligonucleotide Pool by Type




      • DNA




      • RNA






    • India Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • India Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Australia Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Australia Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Rest of Asia-Pacific Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Rest of Asia-Pacific Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Rest of the World Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Rest of the World Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Middle East Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Middle East Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Africa Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Africa Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Oligonucleotide Pool by Type




      • DNA




      • RNA






    • Latin America Oligonucleotide Pool by Application




      • Research




      • Diagnostic & Therapeutics




      • Others






    • Latin America Oligonucleotide Pool by End-User




      • Commercial Research




      • Pure Academic Research




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Market Introduction

2.1 Definition 13

2.2 Scope of Study 13

2.3 Research Objective 13

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.5 Market Structure 14

3 Research Methodology

3.1 Primary Research Methodology 16

3.2 Secondary Research Methodology 18

3.3 Market Size Estimation 19

3.4 Forecast Model 19

4 Market Dynamics

4.1 Introduction 21

4.2 Drivers 21

4.2.1 Big Pharmaceutical Companies Investing in Oligonucleotide Therapeutics for Drug Development 22

4.2.2 Increased Involvement of CMOs in Manufacturing Therapeutic Oligonucleotides 22

4.2.3 Wide Application Areas Offered by the Oligonucleotides 23

4.3 Restraints 23

4.3.1 Complexity in the Manufacturing Technique and Inaccuracy of Oligonucleotides 23

4.4 Opportunities 23

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 25

5.1.1 Bargaining Power of Suppliers 26

5.1.2 Bargaining Power of Buyers 26

5.1.3 Threat of New Entrants 26

5.1.4 Threat of Substitutes 26

5.1.5 Intensity of Rivalry 26

6 Oligonucleotide Pool Market, by Type

6.1 Introduction 28

6.2 DNA 29

6.3 RNA 29

7 Oligonucleotide Pool Market, by Application

7.1 Introduction 31

7.2 Research 33

7.3 Diagnostics & Therapeutics 33

7.4 Other 33

8 Oligonucleotide Pool Market, by End User

8.1 Introduction 35

8.2 Commercial Research 37

8.3 Pure Academic Research 37

8.4 Other 37

9 Global Oligonucleotide Pool Market, by Region

9.1 Introduction 39

9.2 North America 40

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.2.1 US. 43

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.2.2 Canada 44

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3 Europe 45

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.1 Germany 47

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.2 France 48

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.3 UK. 49

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.4 Italy 50

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.5 Spain 51

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.6 Rest of Western Europe 52

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.7 Eastern Europe 53

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4 Asia-Pacific 54

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.1 Australia 57

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.2 Japan 57

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.3 China 58

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.4 India 59

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.5 Rest of Asia-Pacific 60

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5 Middle East & Africa 61

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5.1 Middle East 63

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5.2 Africa 64

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

10 Competitive Landscape

10.1 Introduction 66

11 Company Profiles

11.1 Sigma-Aldrich Co. LLC 68

11.1.1 Company Overview 68

11.1.2 Financial Overview 68

11.1.3 Product Offered 69

11.1.4 4 Key Developments 69

11.1.5 SWOT Analysis 69

11.1.6 Key Strategies 69

11.2 Twist Bioscience 70

11.2.1 Company Overview 70

11.2.2 Financial Overview 70

11.2.3 Product Offered 70

11.2.4 Key Developments 70

11.2.5 SWOT Analysis 71

11.2.6 Key Strategies 71

11.3 MYcroarray 72

11.3.1 Company Overview 72

11.3.2 Financial Overview 72

11.3.3 Treatments Offered 72

11.3.4 1.3.3 Key Developments 72

11.3.5 SWOT Analysis 72

11.3.6 Key Strategies 72

11.4 TriLink BioTechnologies, LLC 73

11.4.1 Company Overview 73

11.4.2 Financial Overview 73

11.4.3 Products Offered 73

11.4.4 Key Developments 73

11.4.5 SWOT Analysis 74

11.4.6 Key Strategies 74

11.5 Agilent Technologies 75

11.5.1 Company Overview 75

11.5.2 Financial Overview 75

11.5.3 Products Offered 76

11.5.4 Key Developments 76

11.5.5 SWOT Analysis 76

11.5.6 Key Strategies 76

11.6 Creative Biogene 77

11.6.1 Company Overview 77

11.6.2 Financial Overview 77

11.6.3 Products Offered 77

11.6.4 Key Developments 77

11.6.5 SWOT Analysis 78

11.6.6 Key Strategies 78

11.7 CustomArray, Inc. 79

11.7.1 Company Overview 79

11.7.2 Financial Overview 79

11.7.3 Products Offered 79

11.7.4 Key Developments 79

11.7.5 SWOT Analysis 79

11.7.6 Key Strategies 79

11.8 Integrated DNA Technologies, Inc. 80

11.8.1 Company Overview 80

11.8.2 Financial Overview 80

11.8.3 Products Offered 80

11.8.4 Key Developments 81

11.8.5 SWOT Analysis 81

11.8.6 Key Strategies 81

12 Appendix

12.1 Discussion Blue Print 83

13 List of Tables

TABLE 1 PRIMARY INTERVIEWS 17

TABLE 2 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 29

TABLE 3 GLOBAL DNA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2023-2032 (USD MILLION) 29

TABLE 4 GLOBAL RNA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2023-2032 (USD MILLION) 29

TABLE 5 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 32

TABLE 6 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 32

TABLE 7 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR RESEARCH, BY REGION, 2023-2032 (USD MILLION) 33

TABLE 8 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR DIAGNOSTICS & THERAPEUTICS, BY REGION 2023-2032 (USD MILLION) 33

TABLE 9 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR OTHER APPLICATIONS, BY REGION 2023-2032 (USD MILLION) 33

TABLE 10 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 36

TABLE 11 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR COMMERCIAL RESEARCH, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 12 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR PURE ACADEMIC RESEARCH, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 13 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR OTHER END USER, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 14 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2023-2032 (USD MILLION) 39

TABLE 15 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 41

TABLE 16 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 41

TABLE 17 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 42

TABLE 18 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 42

TABLE 19 US OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 43

TABLE 20 US OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 43

TABLE 21 US OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 43

TABLE 22 CANADA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 44

TABLE 23 CANADA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 44

TABLE 24 CANADA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 44

TABLE 25 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 46

TABLE 26 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 46

TABLE 27 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 46

TABLE 28 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 47

TABLE 29 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 47

TABLE 30 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 47

TABLE 31 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 47

TABLE 32 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 48

TABLE 33 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 48

TABLE 34 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 48

TABLE 35 UK. OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 36 UK OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 49

TABLE 37 UK OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 49

TABLE 38 ITALY OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 50

TABLE 39 ITALY OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 50

TABLE 40 ITALY OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 50

TABLE 41 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 51

TABLE 42 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 51

TABLE 43 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 51

TABLE 44 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 45 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 52

TABLE 46 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 52

TABLE 47 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 53

TABLE 48 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 53

TABLE 49 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 53

TABLE 50 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 55

TABLE 51 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 55

TABLE 52 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 56

TABLE 53 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 56

TABLE 54 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 57

TABLE 55 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 57

TABLE 56 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 57

TABLE 57 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 57

TABLE 58 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 58

TABLE 59 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 58

TABLE 60 CHINA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 61 CHINA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 58

TABLE 62 CHINA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 59

TABLE 63 INDIA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 59

TABLE 64 INDIA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 59

TABLE 65 INDIA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 59

TABLE 66 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 60

TABLE 67 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 60

TABLE 68 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 60

TABLE 69 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2023-2032 (USD MILLION) 61

TABLE 70 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 62

TABLE 71 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 62

TABLE 72 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 62

TABLE 73 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 63

TABLE 74 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 63

TABLE 75 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 63

TABLE 76 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 77 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 64

TABLE 78 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2023-2032 (USD MILLION) 64

14 List of Figures

FIGURE 1 MARKET STRUCTURE OF THE GLOBAL OLIGONUCLEOTIDE POOL MARKET 14

FIGURE 2 TOP-DOWN AND BOTTOM-UP APPROACHES 19

FIGURE 3 MARKET DYNAMICS 21

FIGURE 4 PORTER’S FIVE FORCES MODEL 25

FIGURE 5 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2022 & 2030 (USD MILLION) 28

FIGURE 6 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2022 & 2030 (USD MILLION) 36

FIGURE 7 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2022 (%) 39

FIGURE 8 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2022 (%) 41

FIGURE 9 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2022 (%) 45

FIGURE 10 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2022 (%) 54

FIGURE 11 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2022 (%) 61

FIGURE 12 GLOBAL OLIGONUCLEOTIDE POOL COMPANY SHARE, 2022 (%) 66

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.